Gilde Healthcare Partners B.V.
Gilde Healthcare is a specialized healthcare investor managing over €3 billion across three fund strategies: Venture&Growth in healthcare, Private Equity in healthcare and Climate Solutions.
In the firm's own words, from its website.
2 additional team members, 12 additional co-investors and affiliates, 71 additional investments, funds and LPs, 3 verified contacts (2 published business email, 1 firm phone)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 1 companyportfolio raising
One portfolio company has new financing on record in 6 months without this firm named on the round; the latest on 9 Jun 2026 ($100M round).
A portfolio company raising again is a follow-on decision for the firm and a co-investment opening for others.
- 3 dealswith Omega Fund Management
Invests most often alongside Omega Fund Management (3 shared deals) and Advent Life Sciences LLP (3 shared deals).
pair last observed on record 1 Oct 2026, not a deal date · The firms it syndicates with are the likeliest to see the same deals and to fill out its rounds.
Measuredshared rounds and portfolio companies on recordFor Founders building a round, co-investorsCo-investors →
People to know
View all people- Beneficial Owner And Managing Partner And Controlling Person Of Stichting Administratiekantoor Gilde Healthcare HoldingWhy: Managing partner: runs the firmNo route on file yet
- Managing Partner, Director BWhy: Managing partner: runs the firmNo route on file yet
- Beneficial Owner And Managing Partner And Controlling Person Of Stichting Administratiekantoor Gilde Healthcare HoldingWhy: Managing partner: runs the firmNo route on file yet
Relationship network
96 connected entities
From financing rounds and every investor named in them, Form ADV and Form D filings, the firm's funds and team, and disclosed LP commitments in the venture capital graph. A round's amount is the size of the round, not money that moved between two investors.
Some relationships on this record are counted rather than named here. They open with the full profile.
Click any name or line for the rounds and sources behind it. Line weight is rounds together; dashed lines are inferred.
- Sponsor
- Company
- Fund or vehicle
- Person
›How strength and recency are read
Co-investors are read from the rounds: three or more shared rounds is a strong observed relationship, two a repeat co-investor, one a single round. Funds and people are structural. Nothing is scored that a reader cannot check.
Darker lines were active in the last 24 months or are current; lighter lines are older or undated.
How am I connected?
Name your firm, a company or a person, and DFX finds the published routes to Gilde Healthcare Partners B.V.: a shared portfolio company or board, a prior employer, a co-investor, a shared LP or service provider. Every step is a filed or published record with its source; none is a guess about who knows whom.
See how you connect to Gilde Healthcare Partners B.V.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Investing
72 companies on record, 0 new in 12 months
Investments on record
What these amounts mean“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.Acquired, Public, Exited and Active are what the firm’s own portfolio card says, read on the date shown when you hover the chip; they are not deal dates. A company with no chip is one whose card states no outcome: DFX does not assume it is active.| Company | Round | Role | Partner | Round size | This investor | Date | Source |
|---|---|---|---|---|---|---|---|
| Ablative Solutions, Inc. | portfolio listing | unknown | unknown | unknown | unknown | Oct 1, 2026 | Fact Firm website |
| Ablynx | portfolio listing | unknown | unknown | unknown | unknown | Oct 1, 2026 | Fact Firm website |
| Acacia Pharma | portfolio listing | unknown | unknown | unknown | unknown | Oct 1, 2026 | Fact Firm website |
Stated thesis versus observed behaviour
- Sectors
- healthcare, biotech, medtech, climate, energy
- Stages
- not stated or not yet read
- Geography
- boston, europe, germany, north america, united states
- Check size
- not stated; DFX does not estimate checks from round sizes
Team
6 current, 1 departed
Decision makers
- Edwin de Graaf · Beneficial Owner And Managing Partner And Controlling Person Of Stichting Administratiekantoor Gilde Healthcare HoldingWhy this person: Managing partner: runs the firm; Named with investment responsibility
- Jasper van Gorp · Managing Partner, Director BWhy this person: Managing partner: runs the firm; Named with investment responsibility
- Pieter van Der Meer · Beneficial Owner And Managing Partner And Controlling Person Of Stichting Administratiekantoor Gilde Healthcare HoldingWhy this person: Managing partner: runs the firm; Named with investment responsibility
Ranked by the role the firm or its filing states, a route on file and deals led. Every reason is read from the record, never inferred. Routes are published by the person or the firm (their bio, the team page or a filing) and are revealed on a plan; data bought from a provider is never shown, and a route printed at a firm the person has since left is held back.
Investment team
How the team is orderedPartners who lead rounds first (rounds led, then deals attributed, then seniority), then the rest of the investment team, then investor relations, finance and operations. A person named by two sources under two spellings is shown once.- Beneficial Owner And Managing Partner And Controlling Person Of Stichting Administratiekantoor Gilde Healthcare Holding
- Managing Partner, Director B
- Beneficial Owner And Managing Partner And Controlling Person Of Stichting Administratiekantoor Gilde Healthcare Holding
Contacts
2 published business email, 1 firm phone on record, each with its source. Values open with the complete profile.
Funds and LPs
5 vehicles, 0 LPs disclosed
Funds and vehicles
What these amounts meanGAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.| Vehicle | Type | Vintage | Lifecycle | Reported GAV | Owners | Form D sold | Latest Form D |
|---|---|---|---|---|---|---|---|
| Coöperatieve Gilde Healthcare Vg VI U.A. | Fund | 2024 adv first reported | Early deployment | $819M Mar 27, 2026 | 93 | unknown | unknown |
| Coöperatieve Gilde Healthcare Private Equity IV U.A. | Fund · ADV: Private Equity Fund | unknown | Unknown | $626M Mar 27, 2026 | 49 | unknown | unknown |
| Cooperatieve Gilde Healthcare V U.A. | Fund | unknown | Unknown | $468M Mar 27, 2026 | 58 | unknown | unknown |
Limited partners
Known LPs and allocators
What these amounts and dates areEach commitment is counted once across the pension tape and the allocator graph. A commitment date prints only when the source printed one; otherwise the row carries the report date. A foundation’s 990-PF line is a holding at fair value, never a commitment. Rows without a fund on the venture graph are commitments to this manager.Relationships across DFX
14 co-investors · on 1 other DFX graph
Co-investors
- 2026-10-013 shared deals · recurring
- 2026-10-013 shared deals · recurring
- 2026-10-012 shared deals · recurring
Across DFX and the capital chainon 1 other DFX graph ShowHide
- The same institution is held on Private Equity, matched by identifier. See which records
Gilde Healthcare Partners B.V. is the same institution as 1 record in Private Equity.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…
Evidence and history
3 dated events, 38 observations from 3 sources
Timeline
- Mar 15, 2024Coöperatieve Gilde Healthcare Vg VI U.A. first reported on Form ADV by Gilde Healthcare Partners B.V. (Venture Capital Fund), GAV $811,981,907
- May 26, 2022Gilde Healthcare Partners B.V. first filed Form ADV (ERA)
- May 26, 2022Coöperatieve Gilde Healthcare Private Equity IV U.A. first reported on Form ADV by Gilde Healthcare Partners B.V. (Private Equity Fund), GAV $543,480,000Fund first reported on Form ADVFundsFactCoöperatieve Gilde Healthcare Private Equity IV U.A.Form ADV
Identity and regulatory footprint
Address, phone, Form ADV filing and ownersForm ADV filed Mar 27, 2026 · 5 private fundsShowHide
- Headquarters
- Utrecht, Netherlandsadviserinfo.sec.gov
- Office address
- unknownadviserinfo.sec.gov
- Business phone
- unknownadviserinfo.sec.gov
- Website
- gildehealthcare.com
- SEC adviser type
- Exempt reporting adviseradviserinfo.sec.gov
- SEC exemption claimed
- Private fund adviseradviserinfo.sec.gov
- Latest Form ADV
- Mar 27, 2026
- Private funds reported
- 5 (3 venture capital funds)adviserinfo.sec.gov
- Private fund gross assets, adviser total
- $2.4Badviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
- Owners on Schedule A
- Gilde Healthcare Holding B.V. (Shareholder), owns 75% or more; Stichting Administratiekantoor Gilde Healthcare Holding (Owner), owns 25% to 50%; Manapouri B.V. (Owner), owns 25% to 50%
Classification history
Classification history
Every classification this record has carried2 on recordShowHide
- Sep 23, 2026Institutional venture firm (probable, 80%)Venture manager, reported GAV $2.4B across 5 vehicles
- Sep 12, 2026Institutional venture firm (probable, 80%)Venture manager, reported GAV $2.4B across 5 vehicles
Evidence
Every observation behind this profile, with its source, date and class
| Fact | Value | Effective | Class | Source |
|---|---|---|---|---|
| SEC exemption claimed | Private fund adviser | Mar 15, 2024 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 27, 2026 | Fact | Form ADV |
| SEC adviser type | Exempt reporting adviser | Mar 15, 2024 | Fact | Form ADV |
| First Form ADV filing | 2022-05-26 | Mar 27, 2026 | Fact | Form ADV |
| First Form ADV filing | 2022-05-26 | Mar 15, 2024 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-30 | Oct 1, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-29 | Sep 30, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-25 | Sep 26, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-23 | Sep 24, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-21 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1+panel:2026-09-22 | Sep 23, 2026 | Fact | Form ADV |
| Adv history loaded | adv-hist-1 | Sep 12, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2026-03-27 | Mar 27, 2026 | Fact | Form ADV |
| Latest Form ADV filing | 2024-03-15 | Mar 15, 2024 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 27, 2026 | Fact | Form ADV |
| Venture share of reported funds | 1 | Mar 15, 2024 | Fact | Form ADV |
| Business phone | Mar 15, 2024 | Fact | Form ADV | |
| Contact page url | Sep 30, 2026 | Fact | ||
| Description | Sep 30, 2026 | Fact | ||
| Headquarters | Utrecht, Netherlands | Mar 15, 2024 | Fact | Form ADV |
| Office address | Mar 15, 2024 | Fact | Form ADV | |
| Legal form | Other (specify) | Mar 15, 2024 | Fact | Form ADV |
| Portfolio page | Sep 30, 2026 | Fact | ||
| Private funds reported | 5 | Mar 27, 2026 | Fact | Form ADV |
| Private funds reported | 5 | Mar 15, 2024 | Fact | Form ADV |
| Private fund gross assets (reported) | $2.4B | Mar 27, 2026 | Fact | Form ADV |
| Private fund gross assets (reported) | $2.4B | Mar 15, 2024 | Fact | Form ADV |
| Schedule a diff | sadiff-1 | Sep 29, 2026 | Fact | Form ADV |
| Stated geography | Boston, europe, germany, north america, united states “geography words on the home page” | Sep 30, 2026 | Fact | |
| Stated sectors | Healthcare, biotech, medtech, climate, energy “sector words on the home page” | Sep 30, 2026 | Fact | |
| Team page | Sep 30, 2026 | Fact | ||
| Venture funds reported | 3 | Mar 27, 2026 | Fact | Form ADV |
| Venture funds reported | 3 | Mar 15, 2024 | Fact | Form ADV |
| Website | Mar 15, 2024 | Fact | Form ADV | |
| Site title | Sep 30, 2026 | Fact |
How this is scored
Scores, classification basis and filing advisersInstitutional venture firm, probable · 2 filing advisers share this firmShowHide
Venture manager, reported GAV $2.4B across 5 vehicles
This firm files as 2 advisers on gildehealthcare.com: Gilde Healthcare Partners US, Inc.. Each keeps its own CRD, funds and filings; the grouping is the website each swore to on Form ADV and is recomputed every pass.
- importance
- gav: 0.72 · funds: 0.42 · people: 0.12 · investments: 0.69 · co investors: 0.46
- active deployment
- investments 12m: 0 · fund raising 18m: 0 · people joined 12m: 0 · vintage within 3y: 1 · latest investment at: not scored
- emerging manager
- fund count: 5 · reported gav: $2.4B · first adv filing: 2022-05-26 · years since first filing: 4.4
Fits, record history and connections
scored matches for this investor, every identity change, every edge
Record history
- Member rows moved to anchor2026-10-01
- Grouped with firm2026-09-12
- Adviser's first ADV filing2022-05-26source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.